Accenture (ACN)
NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-07-09
$139.04+1.35%
Close 2026-07-09 · 1-day change
Reading ACN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ACN free→NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-07-09
Reading ACN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ACN free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
IT Consulting & Other Services is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Accenture's growth model transformation and AI capabilities must continue to justify the price. Revenue grew 6% year over year, and the last quarter beat expectations. It trades at 10× P/E versus a peer median of 11.5×. This suggests the price reflects less growth than expected. A specific risk is the lowered revenue growth guidance, which undermines the core objective. Peer multiples imply a price about 38% above where it trades. Our read is provisional.
Trailing returns as of 2026-07-09. ACN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 27 analysts currently covering ACN (as of Jul 2026).
Based on 16 Wall Street analysts offering 12-month price targets for ACN in the last 4 months.
A consensus fair price across 13 valuation methods, at three horizons. Current price $139.04. As of 2026-07-09. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus IT Consulting & Other Services — fair value, gap to price, and forward P/E.
Advances: Execute growth model transformation with Reinvention Services integration
New AI solutions enhance growth model transformation.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-09. EPS is implied from price ÷ P/E. Not investment advice.
Current $139.04
The last 12 months of price, then the range of analyst 12-month targets from today’s $139.04.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Achieve full-year revenue growth of 3% to 5% in local currency
NATO contract supports revenue growth objective.
Concerns about growth strategy amidst market instability.
Focus on dividends aligns with shareholder return objectives.
Client feedback indicates potential revenue growth issues.
Significant share price decline raises concerns about growth and capital allocation.
Partnership could enhance business transformation capabilities.
Threatens: Achieve full-year revenue growth of 3% to 5% in local currency
Lower guidance impacts revenue growth target.